News
Silence Therapeutics - Additional Listing
RNS Number: 5183 L Silence Therapeutics PLC 19 April 2018. Silence Therapeutics plc, AIM: SLN a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that it has issued and allotted 48,309 new ordinary shares of 5 p each following the exercise of share options under the...
RNS Number: 5183 L Silence Therapeutics PLC 19 April 2018. Silence Therapeutics plc, AIM: SLN a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that it has issued and allotted 48,309 new ordinary shares of 5 p each following the exercise of share options under the...